Japanese PEDMARK Study Reports Significant Reduction in Cisplatin-Related Hearing Loss
This compelling new evidence, stemming from the investigator-initiated STS-J01 study, was officially announced by Fennec Pharmaceuticals and is slated for detailed presentation...
